Latest Posts › Hong Kong Stock Exchange

Share:

Hong Kong GEM Listing Reforms Take Effect

The Situation: The Growth Enterprise Market (the "GEM") listing activities in Hong Kong have been declining since 2019, and there was no new listed issuer on the GEM in 2022....more

Hong Kong Stock Exchange Implements Reforms to Relax IPO "Double Dipping" Restrictions

The Stock Exchange of Hong Kong Limited ("HKEx") introduced a new exemption allowing existing shareholders and cornerstone investors to subscribe for or purchase further securities in an IPO (i.e., to "double dip") under...more

Amendments to Hong Kong Listing Rules Relating to PRC Issuers

The Hong Kong Listing Rule amendments relating to People's Republic of China ("PRC") issuers came into effect on August 1, 2023....more

Hong Kong's New Paperless Listing Regime

In Short - The Situation: In the past few years, the Stock Exchange of Hong Kong Limited (the "Stock Exchange") has taken initiatives to introduce a paperless listing regime and make changes to documentary requirements. ...more

Hong Kong Exchange Publishes Consultation Paper on Listing Regime for Specialist Technology Companies

In Short - The Situation: Hong Kong currently falls behind the United States and Mainland China in terms of the number and market capitalization of companies belonging to the "Specialist Technology Industries."...more

Hong Kong Exchange Publishes Conclusions on Delisting Consultation

The Situation: While a trading suspension gives an issuer an opportunity to remedy the underlying issues that led to the suspension with a view towards trading resumption, the absence of a mechanism under Hong Kong's current...more

Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

The Hong Kong Stock Exchange recently published a Consultation Paper on a Listing Regime for Companies from Emerging and Innovative Sectors, and proposed to introduce a new chapter implementing the listing of...more

Pre-Revenue Biotech Companies Cleared to List on Hong Kong Stock Exchange

The Situation: The Hong Kong Stock Exchange’s failure to recognize that investors are able to evaluate biotech companies in the pre-revenue stages, and its consequent refusal to list those companies for trading, is viewed by...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide